Die behandlung der sialorrhö mit botulinum-toxin

Translated title of the contribution: Treatment of sialorrhea with botulinum toxin: An overview

J. Hagenah*, K. G. Kahl, S. Steinlechner, R. Lencer, C. Klein

*Corresponding author for this work
1 Citation (Scopus)


Hypersalivation (sialorrhea) is a common complaint of patients with neurodegenerative disorders such as Parkinson's disease or amyotrophic lateral sclerosis and a frequently disabling side effect of atypical antipsychotic drugs. Conventional treatment including oral anticholinergic or antihistamine medication is often limited by adverse effects and lack of efficacy. Over the past few years, several studies reported decreased drooling after injections of botulinum toxin into the salivary glands. This review describes the current state of treatment of sialorrhea with botulinum toxin.

Translated title of the contributionTreatment of sialorrhea with botulinum toxin: An overview
Original languageGerman
Issue number4
Pages (from-to)418-425
Number of pages8
Publication statusPublished - 04.2005

Research Areas and Centers

  • Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)


Dive into the research topics of 'Treatment of sialorrhea with botulinum toxin: An overview'. Together they form a unique fingerprint.

Cite this